AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- PHASE1
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BATTLE Program: Sorafenib in Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML
- Status
- COMPLETED
- Phase
- PHASE2
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2